Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 1992DiabetesOpen Access

Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction

View Full Paper
Ask AI
Bookmark
Share

Authors

JCJohn A. CorbettMedical College of WisconsinRTRonald G. TiltonThe University of Texas Medical Branch at GalvestonKCKathy ChangWashington University in St. Louis

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Corbett et al. (1992) studied this question.

synapsesocial.com/papers/6a10bc0cf85e2d3f759f577ehttps://doi.org/10.2337/diab.41.4.552
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels.1991 · 186 citations
  2. 2Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-Linking1986 · 1,149 citations
  3. 3Contraction of diabetic rabbit aorta caused by endothelium-derived PGH2-TxA21989 · 245 citations
  4. 4Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals.1991 · 208 citations
  5. 5EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages.1990 · 508 citations